Brought to you by 
Pasteur-Merieux, Virus Research in flu vaccine alliance
24 Oct 2019
Executive Summary
Pasteur-Merieux has licensed exclusive marketing rights to influenza and Lyme Disease applications of Virus Research Institute's Adjumer vaccine adjuvant technology in the Americas, Europe, Africa, Thailand, and the former USSR.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Pasteur-Merieux, Virus Research in flu vaccine alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice